| molecular function |
|---|
| | GO:0004930 | | G-protein coupled receptor activity | | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
| | GO:0004983 | | neuropeptide Y receptor activity | | Combining with neuropeptide Y to initiate a change in cell activity. |
| | GO:0001602 | | pancreatic polypeptide receptor activity | | Combining with pancreatic polypeptide PP to initiate a change in cell activity. |
| | GO:0001601 | | peptide YY receptor activity | | Combining with gut peptide YY to initiate a change in cell activity. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0004871 | | signal transducer activity | | Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response. |
| biological process |
|---|
| | GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| | GO:0007187 | | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. |
| | GO:0007193 | | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway | | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds through inhibition of adenylyl cyclase activity and a subsequent decrease in the concentration of cyclic AMP (cAMP). |
| | GO:0008015 | | blood circulation | | The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products. |
| | GO:0007166 | | cell surface receptor signaling pathway | | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0007631 | | feeding behavior | | Behavior associated with the intake of food. |
| | GO:0006006 | | glucose metabolic process | | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
| | GO:0007626 | | locomotory behavior | | The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. |
| | GO:0051481 | | negative regulation of cytosolic calcium ion concentration | | Any process that decreases the concentration of calcium ions in the cytosol. |
| | GO:0046888 | | negative regulation of hormone secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell. |
| | GO:0007218 | | neuropeptide signaling pathway | | The series of molecular signals generated as a consequence of a peptide neurotransmitter binding to a cell surface receptor. |
| | GO:0003151 | | outflow tract morphogenesis | | The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. |
| | GO:0030432 | | peristalsis | | A wavelike sequence of involuntary muscular contraction and relaxation that passes along a tubelike structure, such as the intestine, impelling the contents onwards. |
| | GO:0045907 | | positive regulation of vasoconstriction | | Any process that activates or increases the frequency, rate or extent of vasoconstriction. |
| | GO:0008217 | | regulation of blood pressure | | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| | GO:0040014 | | regulation of multicellular organism growth | | Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size. |
| | GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| | GO:0019233 | | sensory perception of pain | | The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process. |
| | GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| cellular component |
|---|
| | GO:0030424 | | axon | | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0005887 | | integral component of plasma membrane | | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0008021 | | synaptic vesicle | | A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. |
Description
